A method for detecting early signs of Alzheimer’s disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method, according to research results from Lund University, Sweden.
Opinions have long been divided as to whether cerebrospinal fluid samples, or PET imaging, are the best tools for detecting early-stage Alzheimer’s disease.
Recently, a method known as amyloid PET imaging was approved for clinical use in Sweden and a special substance which binds to a protein in the brain, β-amyloid, is administered to the patient. This amyloid is a marker for Alzheimer’s changes, which are then mapped with PET imaging. Read more.